FLT3 TK
Collection Requirements
Source: blood or bone marrow
Container: EDTA lavender
Volume:
- Preferred: 3 mL in vacutainer
- Minimum: 1 mL in vacutainer
Special Instructions
Specify newly diagnosed disease or minimal residual disease
Turn Around Time
5-8 days
Availability
Routine
Lab Processing Instructions
Specimen: whole blood or bone marrow
Room temperature or refrigerate
Performing Laboratory
Adele Hall
Adele Hall Lab Section
Molecular Genetics
Instrumentation/Methodology
Multiplex PCR assay with fluorescent fragment analysis
Additional Information
This type of FLT3 mutation, a missense mutation at aspartic acid residue 835, occurs in approximately 7.0% of AML cases. These mutations also appear to be activating, but their clinical significance is unclear.
Reference Ranges
See interpretive report
CPT
81246